Nishioka Yasuhiko

ニシオカヤスヒコ | Nishioka Yasuhiko

Affiliation and department：
Job title： Associate Professor

Research field (4)： Respiratory medicine , Tumor diagnostics and therapeutics , Allergies and connective tissue disease , Immunology

Research keywords (7)： Respirology , Rheumatology , allergy , clinical oncology , 免疫学 , Human Genetics , Inmunology

Research theme for competitive and other funds (17)：

2022 - 2025 肺がん・中皮腫における新たな抗原提示細胞の同定から革新的複合がん免疫療法への展開
2020 - 2023 安全性と有効性を両立した悪性胸膜中皮腫に対するがん細胞選択的抗体医薬の開発
2016 - 2019 Investigation of control factors in tumor specific antibody therapy mediated by ADCC
2013 - 2016 Development of a novel targeting therapy using anti-podoplanin antibody against malignant pleural mesothelioma
2010 - 2015 Development of novel therapy targeting microenvironment in respiratory malignancy

Show all

Papers (131)：

Hiroyuki Kozai, Hirokazu Ogino, Atsushi Mitsuhashi, Na Thi Nguyen, Yuki Tsukazaki, Yohei Yabuki, Ryohiko Ozaki, Hiroto Yoneda, Seidai Sato, Masaki Hanibuchi, et al. Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies. Thoracic cancer. 2023
Hiroto Yoneda, Atsushi Mitsuhashi, Aito Yoshida, Hirokazu Ogino, Satoshi Itakura, Na Thi Nguyen, Hiroshi Nokihara, Seidai Sato, Tsutomu Shinohara, Masaki Hanibuchi, et al. Antipodoplanin antibody enhances the antitumor effects of CTLA-4 blockade against malignant mesothelioma by natural killer cells. Cancer science. 2023
Takeshi Imakura, Seidai Sato, Kazuya Koyama, Hirohisa Ogawa, Takahiro Niimura, Kojin Murakami, Yuya Yamashita, Keiko Haji, Nobuhito Naito, Kozo Kagawa, et al. A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis. Respiratory Research. 2023. 24. 1
Yohei Yabuki, Masaki Hanibuchi, Eiji Takeuchi, Takashi Haku, Takanori Kanematsu, Naoki Nishimura, Yuko Toyoda, Atsushi Mitsuhashi, Kenji Otsuka, Seidai Sato, et al. A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer. Thoracic cancer. 2023. 14. 32. 3232-3239
Seidai Sato, Kazuya Koyama, Hirohisa Ogawa, Kojin Murakami, Takeshi Imakura, Yuya Yamashita, Kozo Kagawa, Hiroshi Kawano, Eiji Hara, Yasuhiko Nishioka. A novel BRD4 degrader, ARV-825, attenuates lung fibrosis through senolysis and antifibrotic effect. Respiratory investigation. 2023. 61. 6. 781-792

ｍore...

MISC (42)：

谷望未, 吉村彰紘, 山田忠明, 大熊裕介, 北台留衣, 竹田隆之, 兼松貴則, 後東久嗣, 米田浩人, 西岡安彦, et al. Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients. 日本呼吸器学会誌(Web). 2020. 9
寺崎泰弘, 國保成暁, 寺崎美佳, 功刀しのぶ, 比島恒和, 木島貴志, 橋本潔, 西岡安彦, 清水章. PPFEの病理学的特徴と弾性線維関連条件のUIPとの比較評価(Pathological features of PPFE with evaluation of elastic fiber related conditions comparing to UIP). 日本病理学会会誌. 2018. 107. 1. 344-344
The Mechanism of Resistance to Anti-angiogenic Therapy Mediated by Fibrocytes in Lung Cancer. 2017. 72. 4. 608-613
森住俊, 佐藤正大, 阿部秀一, 青野純典, 河野弘, 豊田優子, 後東久嗣, 西岡安彦. ニンテダニブのfibrocyte機能に及ぼす作用と抗線維化効果 (第15回肺サーファクタント分子病態研究会). 分子呼吸器病. 2017. 21. 1. 116-119,図巻頭13
寺崎泰弘, 國保成暁, 寺崎美佳, 功刀しのぶ, 比島恒和, 木島貴志, 橋本潔, 西岡安彦, 清水章. 特発性および骨髄移植関連例の上葉優位型肺線維症型病変の病理学的特徴と弾性線維関連病態のUIP型との比較. 日本病理学会会誌. 2016. 105. 1. 454-454

ｍore...

Professional career (1)：

(BLANK) (The University of Tokushima)

Work history (11)：

2022/04 - 現在徳島大学医学部長
2019/04 - 現在徳島大学大学院医歯薬学研究部地域リウマチ・総合内科学分野特任教授(併任)
2011/11 - 現在 The University of Tokushima Institute of Health Biosciences The University of Tokushima Graduate School
2019/04 - 2022/03 The University of Tokushima
2017/04 - 2019/03 The University of Tokushima

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page